Jeil Pharmaceutical Co.,Ltd (KRX: 271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,880
+250 (1.71%)
Oct 8, 2024, 3:30 PM KST

Jeil Pharmaceutical Co.,Ltd Revenue

Jeil Pharmaceutical Co.,Ltd had revenue of 173.18B KRW in the quarter ending June 30, 2024, a decrease of -2.96%. This brings the company's revenue in the last twelve months to 700.47B, down -2.32% year-over-year. In the year 2023, Jeil Pharmaceutical Co.,Ltd had annual revenue of 726.39B with 0.58% growth.

Revenue (ttm)
700.47B
Revenue Growth
-2.32%
P/S Ratio
0.31
Revenue / Employee
724.37M
Employees
967
Market Cap
220.03B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023726.39B4.16B0.58%
Dec 31, 2022722.23B21.54B3.07%
Dec 31, 2021700.69B9.37B1.36%
Dec 31, 2020691.32B19.92B2.97%
Dec 31, 2019671.41B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition